Ecuador approves Oxford-AstraZeneca COVID-19 vaccine for emergency use


By EElena

QUITO, Jan. 24 (Xinhua) -- Ecuador's National Agency for Health Regulation, Control, and Surveillance has approved the emergency use of the Oxford-AstraZeneca vaccine against COVID-19, the Ministry of Public Health reported on Sunday.

The Oxford-AstraZeneca vaccine is the second to gain approval for use in Ecuador, after the Pfizer-BioNTech vaccine.

Ecuador, which as of Saturday had reported 238,232 cases and 9,943 deaths from COVID-19, received on Jan. 20 the first 8,000 doses of the Pfizer-BioNTech vaccine from a first batch of 86,000, which is expected to arrive progressively into February.

This shipment indicated the start of the "zero phase", which involves the immunization of health personnel in critical areas and elderly adults in care centers.

Mass vaccinations for the rest of the population will begin in March, in accordance with international supplies.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

Next In World

Europeans get ‘right to repair’ for some electrical goods
Yemenis reel from poverty, hunger as U.N pleads for funds and war's end
Special Report: Donors bet a U.S. firm could transform disease testing in Africa. Then COVID-19 hit
Europeans push IAEA Iran resolution despite warnings by Russia, Tehran
Explainer: West looks to tougher sanctions as Myanmar violence intensifies
Nigeria's Okonjo-Iweala says 'ready to go' on day one as WTO boss
France's Sarkozy awaits verdict in corruption trial
Russia suspects policeman in new data leak case over Navalny poisoning
EU to propose digital vaccination passport in March, von der Leyen says
Dozens hurt at weekend Thai protest as police use rubber bullets

Stories You'll Enjoy


Vouchers